Cargando…
Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls
During recent years combining GLP-1 and glucagon receptor agonism with the purpose of achieving superior weight loss and metabolic control compared to GLP-1 alone has received much attention. The superior efficacy has been shown by several in preclinical models but has been difficult to reproduce in...
Autores principales: | Simonsen, Lotte, Lau, Jesper, Kruse, Thomas, Guo, Tingqing, McGuire, Jim, Jeppesen, Jacob Fuglsbjerg, Niss, Kristoffer, Sauerberg, Per, Raun, Kirsten, Dornonville de la Cour, Charlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896685/ https://www.ncbi.nlm.nih.gov/pubmed/35245328 http://dx.doi.org/10.1371/journal.pone.0264974 |
Ejemplares similares
-
Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019) -
Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019) -
Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015) -
GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017) -
Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain
por: Farkas, Erzsébet, et al.
Publicado: (2020)